XML 51 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Licensing revenue $ 125,000 $ 125,000 $ 375,000 $ 375,000
Operating expenses:        
Research and development 3,674,239 2,187,317 9,999,972 9,521,937
General and administrative 1,838,287 1,959,903 6,192,835 7,167,740
Total operating expenses 5,512,526 4,147,220 16,192,807 16,689,677
Loss from operations (5,387,526) (4,022,220) (15,817,807) (16,314,677)
Other (expense) income:        
Gain from change in valuation of earn-out milestone liability 85,882 4,114,995 3,088,821 3,567,671
Fair value of warrants issued in connection with amendment to modify GEN-1 earn-out milestone payments (400,000)
Impairment of in-process research and development (4,510,000) (4,510,000)
Investment income 174,439 106,565 432,832 253,750
Interest expense (349,602) (345,728) (1,049,797) (360,759)
Other (expense) income 2 (2,823) 78
Total other (expense) income, net (89,281) (634,166) 2,069,033 (1,049,260)
Net loss $ (5,476,807) $ (4,656,386) $ (13,748,774) $ (17,363,937)
Net loss per common share        
Basic and diluted $ (0.25) $ (0.26) $ (0.67) $ (1.00)
Weighted average shares outstanding        
Basic and diluted 21,662,824 17,801,230 20,524,799 17,447,921